Abstract:
Introduction

34
To meet the growing demands for animal protein, global poultry production will double in health. AIV causes three-to five-million people to fall severely ill, resulting in 250,000 to 42 500,000 fatal cases annually in developing countries (World Health Organization, 2017a).
43
Furthermore, hemagglutinin (HA) and neuraminidase (NA) surface protein combinations are 44 used to characterize influenza viruses. There are 18 HA (H1 -H18) and 11 NA (N1 -N11) 45 subtypes, respectively. Of these subtypes, H5 and H7 are of major concern within the scientific 46 community; as they manifest as low pathogenic infections in waterfowl, which can become Preventing the spread of avian influenza infection is the best way to keep disease outbreaks 54 under control. Prevention starts with effective bio-surveillance through early disease diagnosis.
55
To date there are no pen-side or coop-side tests available for rapid diagnosis. Conventional (ELISA), embryonated egg virus culturing, and chicken pathogenicity tests (Jensen et 
68
Typically these tests take 2-3 weeks to run, require expensive equipment, and require highly 
Nanocomposite deposition on electrodes
154
All electrodes were first cleaned by dropping 10 µL of gold cleaning solution onto the 155 working electrode. After 10 seconds the electrodes were washed thoroughly with DI water.
156
Next, 5 µL of L-polylysine was dropped onto the working electrode and was spread to cover Electrodes were first functionalized by using 1 mM pyrene carboxylic acid (adding a -
165
COOH group to the graphene sheets). 10 µL of pyrene carboxylic acid was deposited onto each 166 working electrode and the electrodes were set to dry for 1 hour. Next, 5 µL of 4 mM EDC was 167 deposited onto the working electrodes followed by 5 µL of 10 mM NHS. The electrodes were 168 left for 10 minutes to allow reaction between EDC and NHS, which was followed by a light DI CdTe quantum dots were conjugated with anti-N1 antibodies (1 µg/mL) using the same 174 EDC/NHS carbodiimide crosslinking. The quantum dots were also incubated overnight at 4 o C.
175
The same procedures were followed to immobilize Anti-H4 antibodies onto the CdTe quantum 
Electrochemical immunosensing of AIV
196
The schematic of electrochemical immunosensing of AIV is illustrated in Fig. 1 . printed gold electrodes were used for these tests. A total of 8 serial dilutions of H5N1 surface 198 protein were used (1 µg/mL to 1 fg/mL), each concentration was tested in triplicates. Similarly, 
Results
232
Nanocomposite characterization
233
In this study, graphene sheets were decorated with non-spherical nanoparticles in a one-pot more particularly panels C and D, it can be confirmed that graphene sheets have been decorated 237 with non-spherical or "spikey" nanoparticles. The resulting nanocomposites were also 238 examined using SEM and EDX to determine their composition (Fig. S1 ). Through elemental 239 analysis, it was found that C, Au, and O were present in the sample, indicating that the graphene 240 sheets were successfully decorated with gold nanoparticles. This was also confirmed via UV-241 visible spectroscopic studies (Fig. S2) . From Fig. S2 , the nanocomposite exhibited the 242 characteristic π -π bond of the polyaromatic C -C at 230 nm for graphene, as well as a second 243 broad peak that was associated with the gold nanoparticles. It is hypothesized that using to electrode surface modifications with the developed nanocomposite (Fig. S3) . From Fig. S3 provided a stable modification, and increased the measured signal. S4. The primary antibody concentration with the lowest current value was found to be 1 µg/mL.
282
This was chosen as the standard as experimentation was continued. The same concentration of 283 secondary antibody was used to form CdTe quantum dot bioconjugates.
284
The proposed immunosensor must provide sensing results more rapidly than current 285 conventional methods. In attempt to reduce the time for analysis, antigen -antibody interaction 286 time studies were conducted (Fig. S5) . It was found that the highest response is received at an 287 incubation period of 60 minutes. This is on-par with current conventional techniques, however,
288
we wanted a sensor that could be used rapidly in a point-of-care fashion. Therefore, we chose 289 and incubation time of 10 minutes, as it provided the second highest response. An incubation 290 time of 10 minutes is much more feasible than 60 minutes when it comes to point of care device 291 employment. Therefore, an incubation time of 10 minutes was used for the H4N6 study. 
H5N1 protein detection in 1X PBS
294
Detection of H5N1 recombinant protein was used as a proof of concept to determine if the 295 immunosensor mechanism would work. The mechanism was later adapted to detect H4N6 296 14 virus. The CV profiles of the various H5N1 protein concentrations are shown in Fig. 3(A) .
297
Upon conducting H5N1 sensing experiments, two negative characteristic peaks were found in 298 the CV profiles, one at -0.35V and the second at -0.75V, corresponding to the CdTe 299 bioconjugate reporters. It was found that the characteristic peaks at -0.75V were more 300 prominent, and thus were used to obtain the current -antigen concentration data shown in Fig.   301 3(B). Fig. 3(B) shows a near sigmoidal relationship between peak current and recombinant 302 protein concentration. It was found that the biosensor could distinctly detect spiked 303 concentrations of H5N1 protein in 1X PBS (pH 7.4) from 1 µg/mL to 10 fg/mL. A linear range 304 exists between 10 ng/mL and 10 pg/mL of recombinant protein (Fig. 3(B) 
H4N6 virus detection in blood 314
The goal of this study was to develop an immunosensor with the capability to detect avian 315 influenza A (H4N6) virus in whole chicken blood. Upon conducting H4N6 sensing 316 experiments in three-parts diluted whole chicken blood, it was found that the sensor can detect 317 the virus with a LOD of 1.28 x 10 -7 HAU (Fig. 4) . The sensor exhibits a detection range from 128 HAU to 1.28 x 10 -7 HAU in blood. It can be observed that a linear response exists for concentrations between 128 HAU and 1.28
333
× 10 -7 HAU, with a sensitivity of 0.718 µA/HAU and a coefficient of determination of 0.975.
334
Additionally, selectivity and cross sensitivity tests were conducted for H4N6 (Fig. 5) . 
Antibody concentration optimization
392
The optimized antibody concentration that was used during testing was 1 µg/mL. However,
393
as concentration was increased beyond 1 µg/mL, the associated peak current began to increase 394 as well (Fig. S4 ). This contradicts electrochemical theory because as antibody concentration is 395 increased, impedance of the electrode should also increase, thus reducing the peak current. 
H5N1 surface protein detection in 1X PBS
402
The results obtained from the cyclic voltammetry studies with respect to recombinant 403 protein concentration (Fig. 3(A) ) exhibit baseline shifts, which make some higher 404 concentration curves appear to have weaker peaks than some lower concentrations. This could in PBS (pH 7.4) based on the obtained sigmoidal data (Fig. 3(B) concentrations have yet to be tested. It can be said that the linear concentration range (Fig. 3(B) 414 inset) shows promise of ultra-sensitive detection of the target antigen. 
H4N6 inactivated virus detection in blood 417
The immunosensor demonstrated ultra-sensitive detection of avian influenza A (H4N6) in HAU (Fig. 4) . The designed immunosensor also exhibited excellent selectivity towards H4N6 420 inactivated virus (Fig. 5) 
